<DOC>
	<DOCNO>NCT01459939</DOCNO>
	<brief_summary>The trial investigator-initiated , double-blind , randomize , placebo-controlled phase III study . After patient receive information study give write informed consent , patient screen . All patient randomize receive standardize rise hip powder match placebo 3 week follow half dose standardize rise hip ( placebo ) remain 12 week study . The patient 's medical history demographic information record . The patient ask question accordance study questionnaire , also ask complete questionnaire regard quality life - finally instruct complete diary . Investigator study nurse take telephone contact subject 3 6 week treatment , subject ask thing go remember take capsule whether complete diary . The contact take 6 week phone mainly guide subject complete questionnaire include VAS scale . The last patient visit take place 12 week . Any side effect report reviewed HybenVital ApS collaboration medical expert .</brief_summary>
	<brief_title>A Double-blind , Randomized , Parallel Group , Fase III Comparative Study With Rose Hip Powder Powder Placebo Given Patients With Mild Moderate Osteoarthritis Knee or/and Hip</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Men woman age 40 + year Osteoarthritis symptoms duration 6 month One WOMACpain visual analogue scale score ( VAS score ) least 35 mm rest Subjective morning joint stiffness Clinical symptom arthritis diagnose ACR ( American College Rheumatology ) criterion Patients treat rise hip extract powder within 3 month screen . Patients treat ginger , avocado soybean extract powder within 3 month screen Patients steroid , TNFalpha DMARD prior trial . Patients receive irregular medical treatment osteoarthritis . Patients suffer joint disease osteoarthritis . Patients abuse alcohol Patients current psychiatric illness , drug / alcohol abuse Patients know allergy rise hip Presence clinically significant medical condition Patients schedule joint major surgery trial . Patients participate another clinical trial , participate another clinical trial within 3 month study . Patients know compliance problem uncooperative . Pregnant lactating woman .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Osteoarthritis</keyword>
</DOC>